Occupational medicine is a concept of preventive medicine concerned with the performance of workers, their health and safety. Occupational medicine is also called industrial medicine. It is a branch of medical science concerned with the health of workers at the workplace, including prevention and treatment of diseases. The secondary objective of occupational medicine is increase productivity of workers and social adjustment. Major benefits of occupational health programs include health risk assessments, fitness programs, workshops, weight loss coaching, health coaching, and nutrition coaching.
Trained occupational medicine specialists diagnose and treat work-related injuries and illnesses. They also work with employees, insurers, and regulators & public health and other health care professionals to create safer workplaces. Common activities of occupational medicine physicians include occupational health-risk/targeted screenings, traditional occupational injury/illness management, primary health care, return-to-work examinations, pre-employment examinations, administrative duties, general health screenings, workers’ compensation, health promotion/disease prevention, evaluation of worksite environment, health education, disability management, training/teaching/mentoring, research, emergency medical care, safety assessments of workplace, health benefits management, and evaluation of effects of worksite activities on external environment.
Government bodies and non-governmental organizations such as the National Institute for Occupational Safety and Health (NIOSH), the Department of Transportation (DOT), the Occupational Safety and Health Administration (OSHA), the Institute of Occupational Medicine (IOM), the Faculty of Occupational Medicine, the European Society for Environmental and Occupational Medicine (EOM), the American College of Occupational and Environmental Medicine (ACOEM), and the Federal Aviation Administration (FAA) are responsible for the creation of the best treatment plans and regulatory examinations.
Key factors driving the global occupational medicines market are rise in awareness among working people about the impact of working environment and diseases & disorders such cancer and back pain.
The global occupational medicines market can be segmented based on application, industry, end-user, and region. In terms of application, the global market can be classified into chronic respiratory diseases, musculoskeletal disorders, skin disorders, pneumoconiosis, psychological disorders, cancer, hearing loss due to noise, disorders caused due to chemicals & vibrations, and others. Based on industry, the global occupational medicines market can be divided into petroleum & mining, agriculture & forestry, pharma & IT, construction & real estate, transportation, manufacturing, and others. In terms of end-user, the global market can be categorized into employers and professionals. The employers segment held the larger share of the global occupational medicines market in 2017.
In terms of region, the global occupational medicines market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for significant share of the global market in 2017, followed by Europe and Asia Pacific. The U.S. held a major share of the market in North America in terms of revenue in 2017. Countries in Europe have a well-established occupational medicines market due to high awareness among people. Rules and regulations in the developed regions giving significant importance to the health of working population also fuel the growth of the occupational medicines market. The market in Asia Pacific is growing rapidly due to expanding infrastructure. Moreover, Asia Pacific is projected to be a highly attractive market in the near future. This is due to the presence of emerging economies such as India, China, and Japan. The occupational medicines market in Latin America and Africa is likely to grow at a rapid pace due to government funding.
Key players operating in the global occupational medicines market include Concentra, Inc., Occucare International, Healthcare Success, LLC, Holzer Health System, U.S. HealthWorks Medical Group, Pfizer, Inc., Johnson & Johnson Services, Inc., Wockhardt Limited, Teva Pharmaceutical Industries Ltd., and AbbVie, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.